Enrique Domínguez-Álvarez
Enrique Domínguez-Álvarez is an expert in Biochemistry at Instituto de Química Orgánica General (Spain). Enrique Domínguez-Álvarez has authored 38 publications, the most recent in 2024. SLR score: 98 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2024
Number : 38
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Products of Selenite/Thiols Interaction Have Reducing Properties, Cleave Plasmid DNA and Decrease Rat Blood Pressure and Tension of Rat Mesenteric Artery. PMID 38676879 — cysteine, blood, acetylcysteine, blood pressure, sulfhydryl compounds, arteries, superoxides, trace elements, mesenteric arteries, dna, hemodynamics, plasmids, glutathione | Biol Trace Elem Res | 2024 | 0 |
| Selenocompounds as Potent Efflux Pump Inhibitors on Gram-positive Bacteria. PMID 39565046 — cells, genes, methicillin-resistant staphylococcus aureus, chemistry, pharmaceutical, neoplasms, aspirin, biofilms, gram-positive bacteria, bacteria, virulence | ChemMedChem | 2024 | 0 |
| Short Communication: Novel Di- and Triselenoesters as Effective Therapeutic Agents Inhibiting Multidrug Resistance Proteins in Breast Cancer Cells. PMID 39273679 — organoselenium compounds, cells, flow cytometry, drug resistance, neoplasm, breast neoplasms, incidence, drug resistance, multiple, communication, neoplasms, breast, therapeutics, atp binding cassette transporter, subfamily b | Int J Mol Sci | 2024 | 1 |
| Di- and Triselenoesters-Promising Drug Candidates for the Future Therapy of Triple-Negative Breast Cancer. PMID 39063006 — organoselenium compounds, cells, cell proliferation, triple negative breast neoplasms, autophagy, breast neoplasms, pharmaceutical preparations, neoplasms, caspase 3, caspases, genes, p53, breast, therapeutics, apoptosis, drug candidate | Int J Mol Sci | 2024 | 3 |
| Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer. PMID 37909996 — doxorubicin, apoptosis, breast neoplasms, esters, mcf-7 cells | Anticancer Res | 2023 | 1 |
LeadR Networks
Main global connection map